Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

HIGHLIGHTS

  • who: Yundong He from the (UNIVERSITY) have published the Article: Targeting signaling pathways in prostate cancer: mechanisms and clinical trials, in the Journal: (JOURNAL) of 12/03/2022
  • what: Overexpression of EZH2, a histone methyltransferase, is a major reason for the increased genomic distribution of H3K27me3 in metastatic PCa.409 EZH2 plays an important role in promoting lineage plasticity and differentiation changes, which are highly associated with NEPC .
  • future: The clinical application of PI3K/AKT/mTOR inhibitors is still limited in PCa and further studies that can identify new biomarkers for patient selection . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?